stitute 
of 
Biomedical 
Imaging 
and 
Bio-
engineering; 
‘‘(D) the provision of funds to enable the 
National Institute of Environmental Health 
Sciences to implement research programs rel-
ative to lung cancer incidence; and 
‘‘(E) the provision of funds to enable the 
National Institute on Minority Health and 
Health Disparities to collaborate on prevention, 
early detection, and disease management re-
search, and to conduct outreach programs in 
order to address the impact of lung cancer on 
minority populations. 
‘‘(2) With respect to the Food and Drug Ad-
ministration, the provision of funds to enable the 
Center for Devices and Radiologic Health to— 
‘‘(A) establish quality standards and guide-
lines for hospitals, outpatient departments, clin-
ics, radiology practices, mobile units, physician 
offices, or other facilities that conduct com-
puted tomography screening for lung cancer; 
‘‘(B) provide for the expedited revision of 
standards and guidelines, as required to accom-
modate technological advances in imaging; and 
VerDate Mar 15 2010 
04:24 Apr 08, 2011
Jkt 099200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H1394.IH
H1394
rfrederick on DSKD9S0YB1PROD with BILLS
‘‘(C) conduct an annual random sample 
survey to review compliance and evaluate dose 
and accuracy performance. 
‘‘(3) With respect to the Centers for Disease 
Control and Prevention— 
‘‘(A) the provision of funds to establish a 
Lung Cancer Early Detection Program that 
provides low-income, uninsured, and under-
served populations that are at high risk for 
lung cancer access to early detection services; 
‘‘(B) the provision of funds to enable the 
National Institute for Occupational Safety and 
Health to conduct research on environmental 
contaminants strongly associated with lung can-
cer in the workplace and implement measures 
to reduce lung cancer risk and provide for an 
early detection program; and 
‘‘(C) a requirement that State, tribal, and 
territorial plans developed under the National 
Comprehensive Cancer Control Program include 
lung cancer mortality reduction measures com-
mensurate with the public health impact of lung 
cancer. 
‘‘(4) With respect to the Agency for Healthcare 
Research and Quality, the annual review of lung 
VerDate Mar 15 2010 
04:24 Apr 08, 2011
Jkt 099200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H1394.IH
H1394
rfrederick on DSKD9S0YB1PROD with BILLS
cancer early detection methods, diagnostic and treat-
ment protocols, and the issuance of updated guide-
lines. 
‘‘(5) The cooperation and coordination of all 
programs for women, minorities, and health dispari-
ties within the Department of Health and Human 
Services to ensure that all aspects of the Lung Can-
cer Mortality Reduction Program adequately address 
the burden of lung cancer on women and minority, 
rural, and underserved populations. 
‘‘(6) The cooperation and coordination of all to-
bacco control and cessation programs within agen-
cies of the Department of Health and Human Serv-
ices to achieve the goals of the Lung Cancer Mor-
tality Reduction Program with particular emphasis 
on the coordination of drug and other cessation 
treatments with early detection protocols.’’. 
SEC. 5. DEPARTMENT OF DEFENSE AND THE DEPARTMENT 
OF VETERANS AFFAIRS. 
The Secretary of Defense and the Secretary of Vet-
erans Affairs shall coordinate with the Secretary of Health 
and Human Services— 
(1) in developing the Lung Cancer Mortality 
Reduction Program under section 399V–6 of the 
Public Health Service Act, as added by section 4; 
VerDate Mar 15 2010 
04:24 Apr 08, 2011
Jkt 099200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H1394.IH
H1394
rfrederick on DSKD9S0YB1PROD with BILLS
(2) in implementing the demonstration project 
under section 6 within the Department of Defense 
and the Department of Veterans Affairs with respect 
to military personnel and veterans whose smoking 
history and exposure to carcinogens during active 
duty service has increased their risk for lung cancer; 
and 
(3) in implementing coordinated care programs 
for military personnel and veterans diagnosed with 
lung cancer. 
SEC. 
6. 
LUNG 
CANCER 
SCREENING 
DEMONSTRATION 
PROJECT. 
(a) SENSE OF THE CONGRESS.—It is the sense of the 
Congress that a national computed tomography lung can-
cer screening demonstration project should be carried out 
expeditiously in order to assess the public health infra-
structure needs and to develop the most effective, safe, 
equitable, and efficient process that will maximize the pub-
lic health benefits of screening. 
(b) DEMONSTRATION PROJECT IN GENERAL.—Not 
later than 1 year after the date of enactment of this Act, 
the Secretary of Health and Human Services (referred to 
in this Act as the ‘‘Secretary’’), in consultation with the 
Secretary of Defense, the Secretary of Veterans Affairs, 
the Director of the National Institutes of Health, the Di-
VerDate Mar 15 2010 
04:24 Apr 08, 2011
Jkt 099200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H1394.IH
H1394
rfrederick on DSKD9S0YB1PROD with BILLS
rector of the Centers for Disease Control and Prevention, 
the Commissioner of Food and Drugs, the Administrator 
of the Centers for Medicare & Medicaid Services, and the 
other members of the Lung Cancer Advisory Board estab-
lished under section 7 of the Lung Cancer Mortality Re-
duction Act of 2011, shall establish a demonstration 
project, to be known as the Lung Cancer Computed To-
mography Screening and Treatment Demonstration 
Project (referred to in this section as the ‘‘demonstration 
project’’). 
(c) PROGRAM REQUIREMENTS.—The Secretary shall 
ensure that the demonstration project— 
(1) identifies the optimal risk populations that 
would benefit from screening; 
(2) develops the most effective, safe, equitable 
and cost-efficient process for screening and early 
disease management; 
(3) allows for continuous improvements in qual-
ity controls for the process; and 
(4) serves as a model for the integration of 
health information technology and the concept of a 
rapid learning into the health care system. 
(d) PARTICIPATION.—The Secretary shall select not 
less than 5 National Cancer Institute Centers, 5 Depart-
ment of Defense Medical Treatment Centers, 5 sites with-
VerDate Mar 15 2010 
04:24 Apr 08, 2011
Jkt 099200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H1394.IH
H1394
rfrederick on DSKD9S0YB1PROD with BILLS